Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy.
Breast cancer is one of the most common types of cancer in females. While drug combinations have shown potential in breast cancer treatments, identifying new effective drug pairs is challenging due to the vast number of possible combinations among available compounds. Efforts have been made to accel...
Main Authors: | Kittisak Taoma, Marasri Ruengjitchatchawalya, Monrudee Liangruksa, Teeraphan Laomettachit |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0298788 |
Similar Items
-
Interpreting drug synergy in breast cancer with deep learning using target-protein inhibition profiles
by: Thanyawee Srithanyarat, et al.
Published: (2024-02-01) -
Enhancing gas sensing properties of novel palladium-decorated zinc oxide surface: a first-principles study
by: Monrudee Liangruksa, et al.
Published: (2021-01-01) -
Construction of Light-Responsive Gene Regulatory Network for Growth, Development and Secondary Metabolite Production in <i>Cordyceps militaris</i>
by: Ammarin In-on, et al.
Published: (2022-01-01) -
Combined Deep Learning and Molecular Modeling Techniques on the Virtual Screening of New mTOR Inhibitors from the Thai Mushroom Database
by: Kewalin Posansee, et al.
Published: (2023-10-01) -
A continuous-time stochastic Boolean model provides a quantitative description of the budding yeast cell cycle
by: Teeraphan Laomettachit, et al.
Published: (2022-11-01)